Market Cap | 3.14M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -914.16k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 10.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -13.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -59.00% |
Recommedations | - | Quick Ratio | - | Shares Outstanding | 96.74M | 52W Low Chg | 2,142.00% |
Insider Own | - | ROA | - | Shares Float | - | Beta | 1.46 |
Inst Own | 0.07% | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00740 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 6,156 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 85,000 | Change | 0.00% |
BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. BioCube, Inc. was incorporated in 2007 and is based in Bohemia, New York.